Your browser doesn't support javascript.
loading
Quantitative assessment of the CD26+ leukemic stem cell compartment in chronic myeloid leukemia: patient-subgroups, prognostic impact, and technical aspects.
Culen, Martin; Borsky, Marek; Nemethova, Veronika; Razga, Filip; Smejkal, Jiri; Jurcek, Tomas; Dvorakova, Dana; Zackova, Daniela; Weinbergerova, Barbora; Semerad, Lukas; Sadovnik, Irina; Eisenwort, Gregor; Herrmann, Harald; Valent, Peter; Mayer, Jiri; Racil, Zdenek.
Affiliation
  • Culen M; Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Borsky M; Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Nemethova V; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
  • Razga F; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
  • Smejkal J; Polymer Institute of the Slovak Academy of Sciences, Bratislava, Slovak Republic.
  • Jurcek T; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
  • Dvorakova D; Polymer Institute of the Slovak Academy of Sciences, Bratislava, Slovak Republic.
  • Zackova D; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
  • Weinbergerova B; Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Semerad L; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
  • Sadovnik I; Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Eisenwort G; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
  • Herrmann H; Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Valent P; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
  • Mayer J; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
  • Racil Z; Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Oncotarget ; 7(22): 33016-24, 2016 May 31.
Article de En | MEDLINE | ID: mdl-27145281
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Cellules souches tumorales / Leucémie myéloïde chronique BCR-ABL positive / Dipeptidyl peptidase 4 Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: Oncotarget Année: 2016 Type de document: Article Pays d'affiliation: République tchèque Pays de publication: États-Unis d'Amérique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Cellules souches tumorales / Leucémie myéloïde chronique BCR-ABL positive / Dipeptidyl peptidase 4 Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: Oncotarget Année: 2016 Type de document: Article Pays d'affiliation: République tchèque Pays de publication: États-Unis d'Amérique